A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India – The Lancet
December 8, 2021
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India The Lancet
source
India's Military Chief Among 13 Killed in Helicopter Crash – Democracy Now!
Return to the UK: How Indian students are going abroad – Study International News
How To Celebrate Diwali In The UK?
About The Author
